The prompt for today was to give my health focus a mascot. I decided to make them a fictional team of superheros. Face it, dealing with these conditions takes a superhero. I am a firm believer that anyone who manages their condition(s) has to be amazing. Living with any chronic illness is tough on the person who has the illness as well as all of their loved ones. It takes a certain strength to live day in and day out with all of what goes with these health conditions. Until one has lived with a chronic illness, they cannot imagine what its like. Even the most understanding, willing to help of loved ones can only guess what it is like for the person with the chronic illness. They get a very good picture and can most likely make a guess that is quite close to the truth, but they can't know how it feels unless they too have a chronic illness. As much as my family is awesome at understanding, accepting and helping me, they can't know what it feels like inside, especially if I cannot describe it. So using Superheroes as mascots is not a stretch! So, here are the superheroes I've found to represent the health conditions I focus on. One note: the "special weapons" sections of information are NOT my own writing! I have used medication information from articles copied from the sources I linked to under each section. I normally do not do that. but it is information about medications so it's not as if I could really supply it in my own words, as I am not a pharmacist, doctor, etc. It is used for educational purposes only.
Title: Arthritis Assassin
Team: Squadron of Salubrity
Report to: Head Honcho of Health
Duties: Assist Head Honcho of Health in fighting the effects of arthritis in ALL of its forms.
Specialized Weapons: Biological Response Modifiers (BRMs), Disease Modifying Anti-Rheumatic Drugs (DMARDs), Glucocorticoids (Cortisone-Related Drugs), Gout Medications, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Osteoporosis Medications
Substances that modify the body's response to infection and disease. The body naturally produces small amounts of these substances. Scientists can produce some of them in the laboratory in large amounts for use in treating cancer, rheumatoid arthritis, and other diseases.
BRMs used in biological therapy include monoclonal antibodies, interferon, interleukin-2 (IL-2), and several types of colony- stimulating factors (CSF, GM-CSF, G-CSF). Interleukin-2 and interferon are BRMs being tested for the treatment of advanced malignant melanoma. Interferon is a BRM now in use to treat hepatitis C.
The side effects of BRM therapy often include flu-like symptoms such as chills, fever, muscle aches, weakness, loss of appetite, nausea, vomiting, and diarrhea. Some patients develop a rash, and some bleed or bruise easily. Interleukin therapy can cause swelling. Depending on the severity of these problems, patients may need to stay in the hospital during treatment. These side effects are usually short-term and go gradually away after treatment stops.
While "first-line" medications (NSAIDs and corticosteroids) can relieve joint inflammation and pain, they do not necessarily prevent joint destruction or deformity. For patients with an aggressively destructive form of rheumatoid arthritis, medications other than NSAIDs and corticosteroids are needed. These "second-line" or "slow-acting" medicines (listed below) may take weeks to months to become effective. They are used for long periods of time, even years, at varying doses. If effective, they can promote remission, thereby retarding the progression of joint destruction and deformity. Sometimes a number of second-line medications are used together as combination therapy.
Hydroxychloroquine (PLAQUENIL) is related to quinine, and is used in the treatment of malaria. It is used over long periods for the treatment of rheumatoid arthritis. Side effects include upset stomach, skin rashes, muscle weakness, and vision changes. Even though vision changes are rare, patients taking PLAQUENIL should be monitored by an eye doctor (ophthalmologist).
Sulfasalazine (AZULFADINE) is an oral medication traditionally used in the treatment of mild to moderately severe inflammatory bowel diseases, such as ulcerative colitis and Crohn's colitis. AZULFADINE is used to treat rheumatoid arthritis in combination with antiinflammatory medications. AZULFADINE is generally well tolerated. Common side effects include rash and upset stomach. Because AZULFADINE is made up of sulfa and salicylate compounds, it should be avoided by patients with known sulfa allergies.
Gold salts have been used to treat rheumatoid arthritis throughout most of this century. Gold thioglucose (SOLGANAL) and gold thiomalate (MYOCHRYSINE) are given by injection, initially on a weekly basis for months to years. Oral gold, auranofin (RIDAURA) was introduced in the 1980's. Side effects of gold (oral and injectable) include skin rash, mouth sores, kidney damage with leakage of protein in the urine, and bone marrow damage with anemia and low white cell count. Patients receiving gold treatment are regularly monitored with blood and urine tests. Oral gold can cause diarrhea.
Enbrel also considered a BRM
Humira also considered a BRM
Remicade also considered a BRM
Glucocorticoids are medications that include cortisone and related drugs. A glucocorticoid is hormone that predominantly affects the metabolism of carbohydrates and, to a lesser extent, fats and proteins (and has other effects). Glucocorticoids are made in the outside portion (the cortex) of the adrenal gland and chemically classed as steroids. Cortisol is the major natural glucocorticoid. The term glucocorticoid also applies to equivalent hormones synthesized in the laboratory. Glucocorticoid drugs are also called corticosteroids.
Corticosteroids have potent anti-inflammatory properties, and are used in a wide variety of inflammatory conditions such as arthritis, colitis, asthma, bronchitis, certain skin rashes, and allergic or inflammatory conditions of the nose and eyes. There are numerous preparations of corticosteroids including oral tablets, capsules, liquids, topical creams and gels, inhalers and eye drops, and injectable and intravenous solutions.
Dosage requirements of corticosteroids vary among individuals and the diseases being treated. In general, the lowest possible effective dose is used. Corticosteroids given in multiple doses throughout the day are more effective, but also more toxic, than if the same total dose is given once daily, or every other day.
of Soft Tissues & Joints
There are three aspects to the medication treatment of gout. First, pain relievers such as TYLENOL or other more potent analgesics are used to manage pain. Secondly, anti-inflammatory agents such as nonsteroidal anti-inflammatory drugs (NSAIDS), colchicine, and corticosteroids are used to decrease joint inflammation. Finally, medications are considered for managing the underlying metabolic derangement that causes high blood levels of uric acid (hyperuricemia) and leads to gout attacks and kidney stones.
Nonsteroidal anti-inflammatory drugs. These are medications that reduce inflammation and do not contain cortisone-related compounds.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed medications for the inflammation of arthritis and other body tissues, such as in tendinitis and bursitis. Examples of NSAIDs include ASPIRIN, indomethacin (INDOCIN), ibuprofen (MOTRIN), naproxen (NAPROSYN), piroxicam (FELDENE), and nabumetone (RELAFEN). The major side effects of NSAIDs are related to the gastrointestinal system. Some 10%-50% of patients are unable to tolerate NSAID treatment because of side effects, including abdominal pain, diarrhea, bloating, heartburn, and upset stomach. Approximately 15% of patients on long-term NSAID treatment develop ulceration of the stomach and duodenum. Even though many of these patients with ulcers do not have symptoms and are unaware of their ulcers, they are at risk of developing serious ulcer complications such as bleeding or perforation of the stomach.
NSAIDs are taken regularly by approximately 33 million Americans!
choline magnesium salicyclate
The best treatment for osteoporosis is prevention. Quitting smoking and curtailing alcohol intake are helpful. Exercise against gravity can reduce bone loss and can even stimulate new bone formation. Additionally, exercise increases agility, strength, and endurance; factors that can reduce accidents. Exercise programs are individualized and should be regular; at least several times weekly. For patients with underlying musculoskeletal disorders, combining exercise with joint protection techniques is important.
Calcium supplements are useful, especially in women. Average women in the United States receive less than 500 milligrams of calcium per day in their diet. The recommended daily allowance (RDA) of calcium intake is 800mg per day. The National Institute of Health Consensus Conference on Osteoporosis has recommended a calcium intake for postmenopausal women of 1000mg per day if they are also taking estrogen and 1500mg per day if they are not taking estrogen.
Estrogen replacement in postmenopausal women is important in the prevention of accelerated bone loss. Estrogen can even reverse the bone loss that occurs after menopause. Estrogen is available orally (PREMARIN, ESTRACE, ESTRATEST, and others) or as a skin patch (ESTRADERM, VIVELLE, and others). Women with certain conditions, such as a history of breast cancer, phlebitis, or stroke may not be candidates for estrogen because of the potential for worsening or inducing recurrences of these conditions.
Vitamin D supplementation has been shown to be of benefit in elderly patients, particularly those in nursing homes. This is probably due to the fact that many patients in nursing homes are vitamin D deficient.
|Brand Name||Generic Name|
References:Arthritis Medications Information on drug classes and medication lists for each class except for BRMs approve after article was written.
Common Drugs and Medications to Treat Rheumatoid Arthritis Information on BRMs not found in article above.
Title: Fibro Fighter
Team: Squadron of Salubrity
Report to: Head Honcho of Health
Duties: Assist Head Honcho of Health in fighting the effects of arthritis, fibromyalgia, and chronic pain.
Specialized Weapons: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Antidepressants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors (SSRIs), Mixed Reuptake Inhibitors, Benzodiazepines, Other Medications For Fibromyalgia, Symptom-Specific Drugs
NSAIDs (nonsteroidal anti-inflammatory drugs) are used to treat inflammation.
Although inflammation is not a symptom of fibromyalgia, NSAIDs also relieve pain. NSAIDs include:
NSAIDs work by inhibiting prostaglandins, which play a role in pain and inflammation. These drugs, some of which are available over-the-counter, may help ease the muscle aches of fibromyalgia. They may also relieve menstrual cramps and the headaches often associated with fibromyalgia.
Perhaps the most useful medications for fibromyalgia are several in the antidepressant class. Antidepressants elevate the levels of certain chemicals in the brain, including serotonin and norepinephrine. Low levels of these chemicals are associated not only with depression, but also with pain and fatigue. Increasing the levels of these chemicals can reduce pain in people who have fibromyalgia. Doctors prescribe several types of antidepressants for people with fibromyalgia.
When taken at bedtime in dosages lower than those used to treat depression, tricyclic antidepressants can help promote restorative sleep in people with fibromyalgia. They also can relax painful muscles and heighten the effects of the body's natural pain-killing substances called endorphins.
Tricyclic antidepressants have been around for almost half a century. Some examples of tricyclic medications used to treat fibromyalgia include:
Selective Serotonin Reuptake Inhibitors (SSRIs)
If a tricyclic antidepressant fails to bring relief, doctors sometimes prescribe a newer type of antidepressant called a SSRI. As with tricyclics, doctors usually prescribe these for people with fibromyalgia in lower dosages than are used to treat depression. By promoting the release of serotonin, these drugs may reduce fatigue and some other symptoms associated with fibromyalgia. The group of SSRIs includes:
SSRIs may be prescribed along with a tricyclic antidepressant. Doctors rarely prescribe SSRIs alone. Because they make people feel more energetic, they also interfere with sleep, which often is already a problem for people with fibromyalgia.
Cymbalta (duloxetine) is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) that is also showing promise.
Mixed Reuptake Inhibitors
Some newer antidepressants raise levels of both serotonin and norepinephrine, and are therefore called mixed reuptake inhibitors. Examples of these drugs include:
Researchers are actively studying the efficacy of these drugs in treating fibromyalgia.
Benzodiazepines help some people with fibromyalgia by relaxing tense, painful muscles and stabilizing the erratic brain waves that can interfere with deep sleep. Benzodiazepines also can relieve the symptoms of restless legs syndrome, which is common among people with fibromyalgia. Restless legs syndrome is characterized by unpleasant sensations in the legs as well as twitching, particularly at night. Because of the potential for addiction, doctors usually prescribe benzodiazepines only for people who have not responded to other therapies. Benzodiazepines include:
Other Medications For Fibromyalgia
Doctors may prescribe other medications, depending on a person's specific symptoms or fibromyalgia-related conditions. For example:
- Gabapentin is being studied as a treatment for fibromyalgia.
- Pregabalin (Lyrica) is the first medicine that is FDA-approved to treat fibromyalgia.
- Modafinil may help with fatigue.
- Sodium oxybate may help with excessive sleepiness.
Other symptom-specific drugs include:
- various headache remedies
- sleep aids such as:
- such as:
Resource:Fibromyalgia Medications - How Is Fibromyalgia Treated?
Title: Chronic Pain Commando
Team: Squadron of Salubrity
Report to: Head Honcho of Health
Duties: Assist Head Honcho of Health in fighting the effects of arthritis, fibromyalgia, and chronic pain.
Specialized Weapons: Medications: Mild pain, Mild to moderate pain, Moderate to severe pain, Opioids, Non-steroidal anti-inflammatory drugs, Antidepressants and antiepileptic drugs, Other analgesics; Procedures; Physical approach: Physiatry, TENS, Acupuncture, LLLT; Psychological approach: Hypnosis
Paracetamol (UK), Tylenol (US) (acetaminophen), or a non steroidal anti-inflammatory drug such as ibuprofen.
Mild to moderate pain
Paracetamol/Tylenol, an NSAID and/or paracetamol/Tylenol in a combination product with a weak opioid such as hydrocodone, may provide greater relief than their separate use.
Moderate to severe pain
When treating moderate to severe pain, the type of the pain, acute or chronic, needs to be considered. The type of pain can result in different medications being prescribed. Certain medications may work better for acute pain, others for chronic pain, and some may work equally well on both. Acute pain medication is for rapid onset of pain such as from an inflicted trauma or to treat post-operative pain. Chronic pain medication is for alleviating long-lasting, ongoing pain.
Morphine is the gold standard to which all narcotics are compared. Fentanyl has the benefit of less histamine release and thus fewer side effects. It can also be administered via transdermal patch which is convenient for chronic pain management. Oxycodone is used across the Americas and Europe for relief of serious chronic pain; its main slow-release formula is known as OxyContin, and short-acting tablets, capsules, syrups and ampules are available making it suitable for acute intractable pain or breakthrough pain. Diamorphine, methadone and buprenorphine are used less frequently. Pethidine, known in North America as meperidine, is not recommended for pain management due to its low potency, short duration of action, and toxicity associated with repeated use. Pentazocine, dextromoramide and dipipanone are also not recommended in new patients except for acute pain where other analgesics are not tolerated or are inappropriate, for pharmacological and misuse-related reasons. Amitriptyline is prescribed for chronic muscular pain in the arms, legs, neck and lower back. While opiates are often used in the management of chronic pain, high doses are associated with an increased risk of opioid overdose.
Opioid medications can provide a short, intermediate or long acting analgesia depending upon the specific properties of the medication and whether it is formulated as an extended release drug. Opioid medications may be administered orally, by injection, via nasal mucosa or oral mucosa, rectally, transdermally, intravenously, epidurally and intrathecally. In chronic pain conditions that are opioid responsive a combination of a long-acting or extended release medication is often prescribed in conjunction with a shorter-acting medication for breakthrough pain, or exacerbations.
Most opioid treatment is oral (tablet, capsule or liquid), but suppositories and skin patches can be prescribed. An opioid injection is rarely needed for patients with chronic pain.
Although opioids are strong analgesics, they do not provide complete analgesia regardless of whether the pain is acute or chronic in origin. Opioids are efficacious analgesics in chronic malignant pain and modestly effective in nonmalignant pain management. However, there are associated adverse effects, especially during the commencement or change in dose. When opioids are used for prolonged periods drug tolerance, chemical dependency, diversion and addiction may occur.
Clinical guidelines for prescribing opioids for chronic pain have been issued by the American Pain Society and the American Academy of Pain Medicine. Included in these guidelines is the importance of assessing the patient for the risk of substance abuse, misuse, or addiction; a personal or family history of substance abuse is the strongest predictor of aberrant drug-taking behavior. Physicians who prescribe opioids should integrate this treatment with any psychotherapeutic intervention the patient may be receiving. The guidelines also recommend monitoring not only the pain but also the level of functioning and the achievement of therapeutic goals. The prescribing physician should be suspicious of abuse when a patient reports a reduction in pain but has no accompanying improvement in function or progress in achieving identified goals.
Non-steroidal anti-inflammatory drugs
The other major group of analgesics are non-steroidal anti-inflammatory drugs (NSAID). Acetaminophen/paracetamol is not always included in this class of medications. However, acetaminophen may be administered as a single medication or in combination with other analgesics (both NSAIDs and opioids). The alternatively prescribed NSAIDs such as ketoprofen and piroxicam, have limited benefit in chronic pain disorders and with long-term use is associated with significant adverse effects. The use of selective NSAIDs designated as selective COX-2 inhibitors have significant cardiovascular and cerebrovascular risks which have limited their utilization
Antidepressants and antiepileptic drugs
Some antidepressant and antiepileptic drugs are used in chronic pain management and act primarily within the pain pathways of the central nervous system, though peripheral mechanisms have been attributed as well. These mechanisms vary and in general are more effective in neuropathic pain disorders as well as complex regional pain syndrome. Drugs such as gabapentin have been widely prescribed for the off-label use of pain control. The list of side effects for these classes of drugs are typically much longer than opiate or NSAID treatments for chronic pain, and many anti-epileptics cannot be suddenly stopped without the risk of seizure.
Other drugs are often used to help analgesics combat various types of pain and parts of the overall pain experience. In addition to gabapentin, the vast majority of which is used off-label for this purpose, orphenadrine, cyclobenzaprine, trazodone and other drugs with anticholinergic properties are useful in conjunction with opioids for neuropathic pain. Orphenadrine and cyclobenzaprine are also muscle relaxants and are therefore particularly useful in painful musculoskeletal conditions. Clonidine has found use as an analgesic for this same purpose and all of the mentioned drugs potentiate the effects of opioids overall.
Pulsed radiofrequency, neuromodulation, direct introduction of medication and nerve ablation may be used to target either the tissue structures and organ/systems responsible for persistent nociception or the nociceptors from the structures implicated as the source of chronic pain.
An intrathecal pump used to deliver very small quantities of medications directly to the spinal fluid. This is similar to epidural infusions used in labour and postoperatively. The major differences are that it is much more common for the drug to be delivered into the spinal fluid (intrathecal) rather than epidurally, and the pump can be fully implanted under the skin. This approach allows a higher dose of the drug to be delivered directly to the site of action, with fewer systemic side effects.
A spinal cord stimulator is an implantable medical device that creates electric impulses and applies them near the dorsal surface of the spinal cord provides a paresthesia ("tingling") sensation that alters the perception of pain by the patient.
Physical medicine and rehabilitation (physiatry/physiotherapy) employs diverse physical techniques such as thermal agents and electrotherapy, as well as therapeutic exercise and behavioral therapy, alone or in tandem with interventional techniques and conventional pharmacotherapy to treat pain, usually as part of an interdisciplinary or multidisciplinary program.
Transcutaneous electrical nerve stimulation has been found to be ineffective for lower back pain, however, it might help with diabetic neuropathy.
Acupuncture involves the insertion and manipulation of needles into specific points on the body to relieve pain or for therapeutic purposes. An analysis of the 13 highest quality studies of pain treatment with acupuncture, published in January 2009 in the British Medical Journal, concluded there was little difference in the effect on pain of real, sham and no acupuncture.
A 2007 review published in the journal Annals of Internal Medicine concluded low-level laser therapy has "not been shown to be effective for either chronic or sub-acute or acute low back pain; and a 2008 Cochrane collaboration review concluded that there was insufficient evidence to support the use of LLLT in the management of low back pain.
Evidence for the usefulness of behavioral therapy (BT) and cognitive behavioral therapy (CBT) in the management of adult chronic pain is generally weak, due partly to the proliferation of techniques of doubtful quality, and the poor quality of reporting in clinical trials. The crucial content of individual interventions has not been isolated and the important contextual elements, such as therapist training and development of treatment manuals, have not been determined. The widely varying nature of the resulting data makes useful systematic review and meta-analysis within the field very difficult.
In 2009 a systematic review of randomized controlled trials (RCTs) of psychological therapies for the management of adult chronic pain (excluding headache) found that "CBT and BT have weak effects in improving pain. CBT and BT have minimal effects on disability associated with chronic pain. CBT and BT are effective in altering mood outcomes, and there is some evidence that these changes are maintained at six months;" and a review of RCTs of psychological therapies for the management of chronic and recurrent pain in children and adolescents, by the same authors, found "Psychological treatments are effective in pain control for children with headache and benefits appear to be maintained. Psychological treatments may also improve pain control for children with musculoskeletal and recurrent abdominal pain. There is little evidence available to estimate effects on disability or mood."
A 2007 review of 13 studies found evidence for the efficacy of hypnosis in the reduction of pain in some conditions, though the number of patients enrolled in the studies was small, bringing up issues of power to detect group differences, and most lacked credible controls for placebo and/or expectation. The authors concluded that "although the findings provide support for the general applicability of hypnosis in the treatment of chronic pain, considerably more research will be needed to fully determine the effects of hypnosis for different chronic-pain conditions." (p. 283).
Pain Management article from Wikipedia